Literature DB >> 12778476

The generalized endotoxic principle.

Ulrich Seydel1, Lynn Hawkins, Andra B Schromm, Holger Heine, Olaf Scheel, Michel H J Koch, Klaus Brandenburg.   

Abstract

Bacterial lipopolysaccharides (endotoxins, LPS) belong to the most potent immunostimulators in mammals. The endotoxic principle of LPS is located in its lipid A moiety, which for Escherichia coli-type LPS consists of a hexaacylated diphosphoryl diglucosamine backbone. This lipid A adopts a cubic inverted aggregate structure from which a conical shape of the molecule can be deduced, whereas the tetraacyl lipid A precursor IVa adopts a cylindrical shape and is endotoxically inactive, but antagonizes active LPS. We hypothesize that non-lipid A amphiphiles with similar physicochemical properties of amphiphilicity, charge, and shape, might mimic the respective lipid A. To test this hypothesis, phospholipid-like amphiphiles with six acyl chains attached to a bisphosphorylated serine-like backbone of varying length replacing the diglucosamine backbone were synthesized. The compound with a short backbone fulfills all criteria of an endotoxic agonist, and that with long backbone fulfills those of an antagonist. This holds true for the human as well as for the murine system. Interestingly, these compounds are inactive in the Limulus amebocyte lysate test which is specific for LPS diglucosamine backbone. These results define a general endotoxic principle and, furthermore, provide new insights into an understanding of early steps of endotoxin action.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12778476     DOI: 10.1002/eji.200323649

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Recent progress in adjuvant discovery for peptide-based subunit vaccines.

Authors:  Fazren Azmi; Abdullah Al Hadi Ahmad Fuaad; Mariusz Skwarczynski; Istvan Toth
Journal:  Hum Vaccin Immunother       Date:  2013-12-03       Impact factor: 3.452

2.  Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages.

Authors:  Susu M Zughaier; William M Shafer; David S Stephens
Journal:  Cell Microbiol       Date:  2005-09       Impact factor: 3.715

3.  Evidence of a specific interaction between new synthetic antisepsis agents and CD14.

Authors:  Matteo Piazza; Liping Yu; Athmane Teghanemt; Theresa Gioannini; Jerrold Weiss; Francesco Peri
Journal:  Biochemistry       Date:  2009-12-29       Impact factor: 3.162

Review 4.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013

Review 5.  Cyanobacterial lipopolysaccharides and human health - a review.

Authors:  Ian Stewart; Philip J Schluter; Glen R Shaw
Journal:  Environ Health       Date:  2006-03-24       Impact factor: 5.984

6.  Self-Organisation, Thermotropic and Lyotropic Properties of Glycolipids Related to their Biological Implications.

Authors:  Patrick Garidel; Yani Kaconis; Lena Heinbockel; Matthias Wulf; Sven Gerber; Ariane Munk; Volkmar Vill; Klaus Brandenburg
Journal:  Open Biochem J       Date:  2015-08-31

7.  Lipopolysaccharides with acylation defects potentiate TLR4 signaling and shape T cell responses.

Authors:  Anna Martirosyan; Yoichiro Ohne; Clara Degos; Laurent Gorvel; Ignacio Moriyón; Sangkon Oh; Jean-Pierre Gorvel
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

Review 8.  Marine compounds with therapeutic potential in gram-negative sepsis.

Authors:  Tamara Solov'eva; Viktoria Davydova; Inna Krasikova; Irina Yermak
Journal:  Mar Drugs       Date:  2013-06-19       Impact factor: 5.118

9.  Biophysical mechanisms of the neutralization of endotoxins by lipopolyamines.

Authors:  Diptesh Sil; Lena Heinbockel; Yani Kaconis; Manfred Rössle; Patrick Garidel; Thomas Gutsmann; Sunil A David; Klaus Brandenburg
Journal:  Open Biochem J       Date:  2013-09-30

10.  I(f) blocking potency of ivabradine is preserved under elevated endotoxin levels in human atrial myocytes.

Authors:  Susanne Scheruebel; Chintan N Koyani; Seth Hallström; Petra Lang; Dieter Platzer; Heinrich Mächler; Karl Lohner; Ernst Malle; Klaus Zorn-Pauly; Brigitte Pelzmann
Journal:  J Mol Cell Cardiol       Date:  2014-02-25       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.